Searchicon: search

New Global Survey Shows Itch is Taking a Toll on Pets, Owners and Vets

U.S. Data Reports and Infographics:

Global Data Reports and Infographics:

A new global survey, “Pet Owner and Vet Perspectives on Canine Pruritus,” reveals that itchy skin and allergic skin disease are among the most common reasons dogs visit the veterinarian. About one in three canine patients in the U.S. (and more than one in four worldwide) are seen for itchy skin or allergic skin disease, and about two in five dogs with skin conditions are newly diagnosed. The impact extends well beyond the dog: 34% of U.S. dog owners (31% globally) say their dog’s allergic skin disease significantly affects their own quality of life, and 61% of U.S. owners (60% globally) have booked vet appointments specifically for their dog’s itchy skin.

Veterinarians feel the strain as well. The chronic, often long‑term nature of allergic skin disease can be tiring to manage, and many dogs cycle through multiple therapies. In the past year alone, 28% of U.S. dog owners and 36% of U.S. veterinarians reported switching therapies used to treat allergic skin disease (29% and 41% globally). “We found that while veterinarians and owners both experience frustrations when communicating with one another about diagnosing the underlying cause of allergic skin disease and treatment plans, both parties have the same goal of finding a solution that is effective, safe and starts working fast,” said Linda Horspool, BVMS, PhD, DipECVPT, FRCVS, Director Scientific Marketing Affairs, Global Marketing Companion Animals, Merck Animal Health.

When it comes to treatment, owners and veterinarians agree that itch relief and safety are essential, with veterinarians also placing high importance on a rapid onset of action. However, their experiences with specific therapies often differ. Many dog owners report using antihistamines, while veterinarians more commonly recommend monoclonal antibodies, JAK inhibitors and corticosteroids. Both groups most often stop treatments because they don’t work well enough, with additional concerns about safety, how long each dose lasts and, for owners, cost.

While only a small number of U.S. dog owners say they would design a treatment to be more affordable, 81% say lower cost, discounts or promotions would be very helpful in managing their dog’s allergic skin disease. More than half of U.S. veterinarians cite the need for more cost‑effective options, and many also note a lack of suitable treatments for younger dogs, including puppies. The survey’s qualitative findings further show that allergic skin disease is often misunderstood as a short‑term issue, leading to unrealistic expectations, gaps in communication and challenges with adherence to treatment plans.

Across all countries, owners and veterinarians share the same ultimate goal: fast, targeted, effective and safe relief that is easier to administer, more affordable and suitable for dogs of all ages. The survey highlights the need for rapid‑onset, targeted anti‑itch therapies, better support for long‑term management and clearer communication between veterinarians and pet owners.